KKRTICKER
KKR & Co. Inc.
Congress has disclosed 23 buys and 25 sells of KKR (KKR & Co. Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
23
Buy
25
Sell
-2
Net
12
Active politicians
Round-trip watch Still on the books
Members who disclosed buying KKR and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Jonathan Jackson | 2025-03-24 | $120.75 | $94.39 | -21.8% | underwater |
| Gilbert Cisneros | 2025-10-17 | $116.75 | $94.39 | -19.2% | underwater |
| Alan Armstrong | 2026-03-27 | $88.16 | $94.39 | +7.1% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Finance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
26.88
▲ pricier than
Finance (median 17.2)
how it's calculated
P/E = price ÷ earnings per share
$94.39 ÷ $3.51 = 26.88
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.73
▲ pricier than
Finance (median 1.8)
how it's calculated
P/B = price ÷ book value per share
$94.39 ÷ $34.59 = 2.73
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Finance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10820 | Epstein Wall Street Records Act of 2026 | Finance and Financial Sector | 2026-10-15 |
| HR 10821 | To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. | Finance and Financial Sector | 2026-10-15 |
| S 4395 | Terrorism Risk Insurance Program Reauthorization Act of 2026 | Finance and Financial Sector | 2026-10-05 |
| S 1564 | Floodplain Enhancement and Recovery Act | Finance and Financial Sector | 2026-10-05 |
| S 5644 | A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. | Finance and Financial Sector | 2026-09-30 |
48 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Spouse | 2026-04-13 | 21 days | +5.3% | $1K–$15K | 17.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2026-03-30 | 3 days | +1.0% | $15K–$50K | 31.8 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider convergence · strong | Self | 2026-03-27 | 116 days | +9.9% | $1K–$15K | 89.2 | ↗ eFD |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-11-19 | 15 days | +9.3% | $1K–$15K <0.1% of NW |
64.9 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-11-07 | 35 days | +12.8% | $1K–$15K 0.1% of NW |
24.5 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-10-17 | 26 days | +4.7% | $1K–$15K 0.1% of NW |
27.5 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
30.3 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · moderate | Self · 150 Main Street Trust > Bank of America | 2025-05-07 | 28 days | +3.9% | $1K–$15K 0.1% of NW |
63.0 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-21 | 21 days | +28.0% | $1K–$15K <0.1% of NW |
69.0 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence · moderate | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-14 | 29 days | +23.2% | $1K–$15K <0.1% of NW |
69.2 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
82.6 | ↗ filing |
| Jonathan Jackson | House | SELL ◆ insider convergence · moderate | Spouse · Morgan Stanley - Rollover IRA | 2025-04-04 | 121 days | +53.9% | $1K–$15K 0.3% of NW |
31.8 | ↗ filing |
| Jonathan Jackson | House | BUY ◆ insider convergence · moderate | Spouse · Morgan Stanley - Rollover IRA | 2025-03-24 | 132 days | +17.1% | $1K–$15K 0.3% of NW |
33.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2025-03-12 | 26 days | -14.7% | $1K–$15K | 12.3 | ↗ filing |
| Jonathan Jackson | House | BUY ◆ insider divergence | Spouse · Morgan Stanley - Rollover IRA | 2025-03-03 | 153 days | +7.3% | $1K–$15K 0.3% of NW |
67.2 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-02-27 | 6 days | -6.9% | $1K–$15K <0.1% of NW |
60.4 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-02-26 | 7 days | -7.3% | $1K–$15K <0.1% of NW |
62.4 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-11-19 | 14 days | +3.4% | $1K–$15K <0.1% of NW |
69.0 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | +4.6% | $1K–$15K 0.8% of NW |
69.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-10-17 | 19 days | +1.0% | $1K–$15K <0.1% of NW |
66.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence | Child | 2024-07-02 | 34 days | — | $1K–$15K | 2.6 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-05-10 | 26 days | — | $1K–$15K <0.1% of NW |
84.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-05-06 | 29 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-05-02 | 33 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-05-01 | 34 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-03-21 | 13 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-02-15 | 19 days | — | $1K–$15K | 2.6 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-02-08 | 26 days | — | $1K–$15K <0.1% of NW |
97.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-02-06 | 28 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-02-01 | 33 days | — | $1K–$15K | 4.5 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-11-14 | 21 days | — | $1K–$15K | 5.5 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-11-09 | 26 days | — | $1K–$15K | 6.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-10-20 | 17 days | — | $1K–$15K | 8.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-09-14 | 21 days | — | $1K–$15K | 19.6 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X141 | 2023-09-08 | 28 days | — | $1K–$15K 0.3% of NW |
19.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence | Child | 2023-05-10 | 23 days | — | $1K–$15K | 15.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-02-15 | 14 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-02-08 | 21 days | — | $1K–$15K | 52.4 | ↗ filing |
| Shri Thanedar | House | SELL ◆ insider convergence | Self | 2023-01-23 | 7 days | — | $15K–$50K 0.1% of NW |
94.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-01-11 | 22 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2022-01-13 | 33 days | — | $1K–$15K 0.3% of NW |
15.7 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2022-01-12 | 34 days | — | $1K–$15K 0.3% of NW |
22.3 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-10-06 | 22 days | — | $1K–$15K 0.3% of NW |
40.4 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-09-30 | 28 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Patrick Fallon | House | BUY | Self | 2021-05-03 | 57 days | — | $15K–$50K 0.3% of NW |
90.9 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Raúl Grijalva | House | SELL OTHER | Spouse | 2015-04-28 | 16 days | — | $1K–$15K | 40.4 | ↗ filing |
| Raúl Grijalva | House | BUY OTHER | Spouse | 2015-04-10 | 34 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in KKR — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
34
Congress trades with insider convergence
6
…with insider divergence
102
Insider open-market trades
Of the congressional trades in KKR, 34 coincided with corporate insiders moving the same way within 60 days, and 6 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-03 | HOLMES DANE E | C-suite | SELL | $1.1M | ↗ EDGAR |
| 2026-06-05 | KKR Group Partnership L.P. | Other | SELL | $857.5M | ↗ EDGAR |
| 2026-03-04 | KKR Group Partnership L.P. | Other | SELL | $807.5M | ↗ EDGAR |
| 2026-03-04 | BARAKETT TIMOTHY R | Director | BUY | $4.7M | ↗ EDGAR |
| 2026-03-02 | Dillon Mary N | Director | BUY | $2.0M | ↗ EDGAR |
| 2026-02-27 | BAE JOSEPH Y | C-suite | BUY | $4.4M | ↗ EDGAR |
| 2026-02-27 | NUTTALL SCOTT C | C-suite | BUY | $4.4M | ↗ EDGAR |
| 2026-02-17 | NUTTALL SCOTT C | C-suite | BUY | $3.6M | ↗ EDGAR |
| 2026-02-17 | NUTTALL SCOTT C | C-suite | BUY | $9.3M | ↗ EDGAR |
| 2026-02-17 | NUTTALL SCOTT C | C-suite | BUY | $12K | ↗ EDGAR |
| 2026-02-17 | BAE JOSEPH Y | C-suite | BUY | $2.3M | ↗ EDGAR |
| 2026-02-17 | BAE JOSEPH Y | C-suite | BUY | $876K | ↗ EDGAR |
| 2026-02-17 | BAE JOSEPH Y | C-suite | BUY | $6.5M | ↗ EDGAR |
| 2026-02-17 | BAE JOSEPH Y | C-suite | BUY | $3.1M | ↗ EDGAR |
| 2026-02-17 | Cohler Matt | Director | BUY | $4.5M | ↗ EDGAR |
| 2026-02-09 | BARAKETT TIMOTHY R | Director | BUY | $5.2M | ↗ EDGAR |
| 2025-10-22 | KKR Group Partnership L.P. | Other | SELL | $424.4M | ↗ EDGAR |
| 2025-08-07 | ROBERTS GEORGE R | Director | SELL | $116.8M | ↗ EDGAR |
| 2025-06-24 | KKR Group Partnership L.P. | Other | SELL | $44.4M | ↗ EDGAR |
| 2025-06-12 | KKR Group Partnership L.P. | Other | SELL | $281.1M | ↗ EDGAR |
| 2025-06-06 | KKR Group Partnership L.P. | Other | SELL | $167.0M | ↗ EDGAR |
| 2025-06-02 | KRAVIS HENRY R | Director | SELL | $137.8M | ↗ EDGAR |
| 2025-06-02 | KRAVIS HENRY R | Director | SELL | $15.9M | ↗ EDGAR |
| 2025-06-02 | ROBERTS GEORGE R | Director | SELL | $142.6M | ↗ EDGAR |
| 2025-05-22 | BARAKETT TIMOTHY R | Director | BUY | $4.1M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-09-03 | HOLMES DANE E C-suite | SELL | $1.1M |
| ◆ insider | 2026-06-05 | KKR Group Partnership L.P. Other | SELL | $857.5M |
| Congress | 2026-04-13 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-03-30 | Rohit Khanna | BUY | $15K–$50K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-03-04 | KKR Group Partnership L.P. Other | SELL | $807.5M |
| ◆ insider | 2026-03-04 | BARAKETT TIMOTHY R Director | BUY | $4.7M |
| ◆ insider | 2026-03-02 | Dillon Mary N Director | BUY | $2.0M |
| ◆ insider | 2026-02-27 | BAE JOSEPH Y C-suite | BUY | $4.4M |
| ◆ insider | 2026-02-27 | NUTTALL SCOTT C C-suite | BUY | $4.4M |
| ◆ insider | 2026-02-17 | NUTTALL SCOTT C C-suite | BUY | $3.6M |
| ◆ insider | 2026-02-17 | NUTTALL SCOTT C C-suite | BUY | $9.3M |
| ◆ insider | 2026-02-17 | NUTTALL SCOTT C C-suite | BUY | $12K |
| ◆ insider | 2026-02-17 | BAE JOSEPH Y C-suite | BUY | $2.3M |
| ◆ insider | 2026-02-17 | BAE JOSEPH Y C-suite | BUY | $876K |
| ◆ insider | 2026-02-17 | BAE JOSEPH Y C-suite | BUY | $6.5M |
| ◆ insider | 2026-02-17 | BAE JOSEPH Y C-suite | BUY | $3.1M |
| ◆ insider | 2026-02-17 | Cohler Matt Director | BUY | $4.5M |
| ◆ insider | 2026-02-09 | BARAKETT TIMOTHY R Director | BUY | $5.2M |
| Congress | 2025-11-19 | Josh Gottheimer | SELL | $1K–$15K |
| Congress | 2025-11-07 | Gilbert Cisneros | SELL | $1K–$15K |
| ◆ insider | 2025-10-22 | KKR Group Partnership L.P. Other | SELL | $424.4M |
| Congress | 2025-10-17 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2025-09-23 | Valerie Hoyle | SELL | $1K–$15K |
FAQ Common questions
How much has Congress traded KKR?
23 disclosed buys and 25 sells of KKR (KKR & Co. Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade KKR?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.